After closing yesterday at $746.36 with a 1% drop, Tesla (TSLA) stock is down around 6% now. It is predicted that Tesla stock price would hit $2,000 in 2019.
Moderna (MRNA) stock is one of the biotech firms taking the lead in the current fight against COVID-19. The company could see fortunes change soon. Yesterday, MRNA gained over 10%, today in the pre-market, it is up another 3.89%.
With the global aviation industry coming under major distress, Richard Branson has reached out to the U.K. government for a loan to keep Virgin airline business afloat and ensure that the job losses are reduced. SPCE stock is down now.
Under the given conditions, Disney (DIS) stock is suffering. In comparison with 2019, Disney stock lost 26.27%. At the moment of writing, it is 4.19% down, trading at $102.28.
Facebook’s new gaming app will be mainly focused on watching and making game live streams. Android users anywhere in the world can try it today. After Apple approves the app, it will be available on iOS as well. FB stock is slightly down.
Inovio Pharmaceuticals received $6.9 million to work with the International Vaccine Institute (IVI) and the Korea National Institute of Health (KNIH) and start Phase 1/2 clinical testing of its INO-4800 vaccine. Following the news, INO stock is up.
On April 29, Tesla will release the first-quarter 2020 earnings. Analysts have already made their predictions, and now we have to wait to see whether Tesla has beat their expectations or not. Today TSLA stock is down in the pre-market.
After Moderna announced it received $483 million in federal funding to speed up the development of the coronavirus vaccine, MRNA stock hiked 15%.
Recently, Tesla got in hot water, as its founder Elon Musk seems to have misled shareholders. Regulators considered his tweet about going private an attempt to defraud shareholders and manipulate Tesla (TSLA) stock price.
Alphabet (GOOGL) stock plunged yesterday as the company decided to slow down hiring new employees for the rest of this year and reduce spending in such areas as data centers.
Over 80 million U.S citizens are set to receive the coronavirus stimulus checks in their bank accounts in the nearest days, the next batch of the checks will be sent later on.
According to Jim Cramer, Johnson & Johnson COVID-19 vaccine candidate will help the public overcome fears of going out and spending money on entertainment. Meanwhile, JNJ stock went 1% up yesterday.
Johnson & Johnson is planning to produce close to 1 billion COVID-19 doses by March 2021 if its human trials go well. Meanwhile, despite a small fall now, JNJ is slowly climbing higher and higher.
NBCUniversal says that it plans to make the best use of the quarantine period by launching its Peacock streaming service. As a result, NBCUniversal is now gearing up to prepare the launch and tap more customers at the right time.
Within the partnership, Sanofi will contribute its S-protein COVID-19 antigen based on recombinant DNA technology, while GlaxoSmithKline will implement its proven pandemic adjuvant technology.